fda warning letter hims & hers compounded semaglutide september 2025 From Crackdown to Collaboration: Letters and the Hims-Novo Nordisk Deal Signal a New Era for GLP-1 Drugs September 15, 2025: Telehealth company

That makes it attractive for patients who want a more physiologic approach to lean-mass preservation, healthier aging, and improved recovery while body fat is being reduced

These medications are commonly used to manage both type 2 diabetes (T2D) and weight-related disorders

All I can say is that she has rejoined the pool. Shortly afterward, Williams was asked directly about the speculation in an interview on the Today show, but declined to give a clear answer: Its not a yes, and its not a no

Citation193 Therefore, further clinical trials are needed to validate the efficacy and safety of these agents in human populations